Literature DB >> 24816726

Trop2 gene: a novel target for cervical cancer treatment.

Xiaoqi Liu1, Siqi Li, Faping Yi.   

Abstract

OBJECT: Trop2 plays an important role in proliferation and invasion of tumors. Extensive research has shown that the expression level of Trop2 is closely related to the progress of cervical diseases. This study was to explore the effects of Trop2 on cell proliferation and apoptosis in cervical cancer.
METHODS: Trop2 was knocked down by shRNA in CaSki cells. The expression level of mRNA and protein was detected by real-time PCR and western blot, respectively. Cell proliferation was determined by CCK-8 and clone formation assay; apoptosis was measured by flow cytometry; cell cycle and apoptosis-related proteins cyclinD1, P53, bcl-2, bax, caspase 3, 8 and 9 were analyzed as well to investigate possible mechanism.
RESULTS: Trop2 expression was effectively repressed in CaSki cells by Trop2 shRNA, which resulted in inhibition of proliferation and colony formation, whereas apoptosis rate was significantly increased. Furthermore, in Trop2 knockdown CaSki cells, the expression of cyclinD1 and bcl-2 was significantly down-regulated, while that of P53 and bax was up-regulated accompanied by increased activities of caspase 9 and 3 but not caspase 8.
CONCLUSIONS: Trop2 is important in proliferation and apoptosis regulation in CaSki cells, which may become a novel target for cervical cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24816726     DOI: 10.1007/s00432-014-1696-1

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  51 in total

Review 1.  Screening for cervical carcinoma.

Authors:  C A Warner; D J McCance
Journal:  Med Lab Sci       Date:  1989-07

Review 2.  Vaccination strategies for the prevention of cervical cancer.

Authors:  James Maclean; Edward P Rybicki; Anna-Lise Williamson
Journal:  Expert Rev Anticancer Ther       Date:  2005-02       Impact factor: 4.512

3.  Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody.

Authors:  Joyce Varughese; Emiliano Cocco; Stefania Bellone; Elena Ratner; Dan-Arin Silasi; Masoud Azodi; Peter E Schwartz; Thomas J Rutherford; Natalia Buza; Sergio Pecorelli; Alessandro D Santin
Journal:  Am J Obstet Gynecol       Date:  2011-07-13       Impact factor: 8.661

4.  Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

Authors:  J Yang; X Liu; K Bhalla; C N Kim; A M Ibrado; J Cai; T I Peng; D P Jones; X Wang
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

5.  Production of tumor-associated antigen, TA-4, by the CaSki cervical carcinoma cell line.

Authors:  R O Hussa; T Maruo; J L Strobel; R A Pattillo; M Mochizuki
Journal:  Obstet Gynecol       Date:  1986-06       Impact factor: 7.661

6.  Assignment of TACSTD1 (alias TROP1, M4S1) to human chromosome 2p21 and refinement of mapping of TACSTD2 (alias TROP2, M1S1) to human chromosome 1p32 by in situ hybridization.

Authors:  G Calabrese; C Crescenzi; E Morizio; G Palka; E Guerra; S Alberti
Journal:  Cytogenet Cell Genet       Date:  2001

7.  Expression of Trop2 cell surface glycoprotein in normal and tumor tissues: potential implications as a cancer therapeutic target.

Authors:  Lara P Stepan; Esther S Trueblood; Kari Hale; John Babcook; Luis Borges; Claire L Sutherland
Journal:  J Histochem Cytochem       Date:  2011-05-06       Impact factor: 2.479

8.  Trop-2 overexpression in poorly differentiated endometrial endometrioid carcinoma: implications for immunotherapy with hRS7, a humanized anti-trop-2 monoclonal antibody.

Authors:  Eliana Bignotti; Antonella Ravaggi; Chiara Romani; Marcella Falchetti; Silvia Lonardi; Fabio Facchetti; Sergio Pecorelli; Joyce Varughese; Emiliano Cocco; Stefania Bellone; Peter E Schwartz; Thomas J Rutherford; Alessandro D Santin
Journal:  Int J Gynecol Cancer       Date:  2011-12       Impact factor: 3.437

9.  Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas.

Authors:  M Fornaro; R Dell'Arciprete; M Stella; C Bucci; M Nutini; M G Capri; S Alberti
Journal:  Int J Cancer       Date:  1995-09-04       Impact factor: 7.396

10.  TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma.

Authors:  Jau-Chen Lin; Yi-Ying Wu; Jing-Yi Wu; Tzu-Chieh Lin; Chen-Tu Wu; Yih-Leong Chang; Yuh-Shan Jou; Tse-Ming Hong; Pan-Chyr Yang
Journal:  EMBO Mol Med       Date:  2012-03-15       Impact factor: 12.137

View more
  4 in total

1.  Selection and identification of novel peptides specifically targeting human cervical cancer.

Authors:  Xiaomin Liu; Jingwen Peng; Jie He; Qiaoran Li; Jianbin Zhou; Xiaoqiu Liang; Shengsong Tang
Journal:  Amino Acids       Date:  2018-02-12       Impact factor: 3.520

2.  Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment.

Authors:  Juan Carlos Higareda-Almaraz; Juan S Ruiz-Moreno; Jana Klimentova; Daniela Barbieri; Raquel Salvador-Gallego; Regina Ly; Ilse A Valtierra-Gutierrez; Christiane Dinsart; Gabriel A Rabinovich; Jiri Stulik; Frank Rösl; Bladimiro Rincon-Orozco
Journal:  BMC Cancer       Date:  2016-08-24       Impact factor: 4.430

3.  TROP2 increases growth and metastasis of human oral squamous cell carcinoma through activation of the PI3K/Akt signaling pathway.

Authors:  Genxiong Tang; Qi Tang; Lizhou Jia; Yuan Chen; Liangyuan Lin; Xingwang Kuai; Aixiu Gong; Zhengqing Feng
Journal:  Int J Mol Med       Date:  2019-10-21       Impact factor: 4.101

4.  Prognostic role and clinical significance of trophoblast cell surface antigen 2 in various carcinomas.

Authors:  Peng Xu; Yang Zhao; Kang Liu; Shuai Lin; Xinghan Liu; Meng Wang; Pengtao Yang; Tian Tian; Yu-Yao Zhu; Zhijun Dai
Journal:  Cancer Manag Res       Date:  2017-12-12       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.